Serum levels of ghrelin and obestatin in children with symptoms suggestive of delayed gastric emptying of unclear etiology

Efstratios Saliakellisa, Nikolaos Karatzasb, Ioannis Iakovoub, Evangelia Farmakic, Georgios Varlamisa, Maria Fotoulakia

Papageorgiou Hospital; Ippokratio Hospital, Aristotle University, Thessaloniki, Greece

a4th Pediatric Department (Efstratios Saliakellis, Georgios Varlamis, Maria Fotoulaki), Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece; b3rd Nuclear Medicine Department (Nikolaos Karatzas, Ioannis Iakovou), Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece; c1st Pediatric Department, Ippokratio Hospital, Aristotle University (Evangelia Farmaki), Thessaloniki, Greece
Correspondence to: Efstratios Saliakellis MD, PhD, 4th Department of Pediatrics, Aristotle University of Thessaloniki, Medical School, Papageorgiou Hospital, Ring Road Nea Efkarpia, 56403 Thessaloniki, Greece, Tel.: +30 2313 323000, Fax: +30 2313 323918, e-mail: efstratios.saliakellis@gmail.com
Received 18 March 2015; accepted 30 May 2015
© 2015 Hellenic Society of Gastroenterology

Abstract

Background Ghrelin and obestatin are peptides of the gut-brain axis affecting appetite and gastrointestinal motility.

Methods We conducted a cross-sectional, case-control study to determine pre- and postprandial serum levels of total ghrelin and obestatin along with gastric emptying scintigraphy in children with symptoms suggestive of delayed gastric emptying time (GET), not attributable to any identifiable cause.

Results Twenty children with symptoms suggestive of delayed GET, of whom 9 had delayed GET, and 20 age-matched healthy children were enrolled. Preprandial ghrelin and obestatin were higher compared to controls (GHR mean level in patients and controls: 1162 pg/mL and 401 pg/mL respectively; P<0.05; OB mean level in patients and controls: 417 pg/mL and 325 pg/mL respectively; not statistically significant). Postprandial ghrelin was significantly decreased in the subgroup of patients with delayed GET (GHR mean level in children with normal and prolonged GET: 1237 pg/mL and 584 pg/mL respectively; P<0.05).

Conclusion Obestatin and ghrelin were deranged in children with symptoms indicative of delayed GET of unexplained etiology. Gastric emptying was prolonged in almost half of the patients thus gastric emptying scintigraphy should be considered in the investigation of children with such symptomatology.

Keywords: Children, ghrelin, obestatin, delayed gastric emptying, gastric emptying scintigraphy

Ann Gastroenterol 2015; 28 (4): 452-456


Introduction

Ghrelin (GHR) and obestatin (OB) are peptides secreted by the stomach [1]. The gene of human GHR is located on chromosome 3p26-p25 and encodes a polypeptide called preproghrelin which undergoes a stepwise proteolytic cleavage generating GHR and subsequently OB [2]. GHR is orexigenic and promotes gastrointestinal (GI) motility whereas OB exerts anorexigenic effects, decelerates gastric emptying time and small bowel activity and reduces body weight [3].

Early satiety, bloating, nausea and vomiting are symptoms frequently encountered in pediatrics; delayed gastric emptying time (GET) has been implicated as an underlying pathophysiological mechanism for the abovementioned symptoms [4,5].

We hypothesized that GHR and OB are implicated in the pathogenesis of delayed GET, in the absence of mechanical gastric outlet obstruction, in children presenting with symptoms of delayed GET that persist >6 months and for which no cause was identified [6,7].

The aim of this study was to assess GET as well as pre- and postprandial levels of GHR and OB and examine their association.

Patients and methods

Study subjects

All children referred for further investigation at a tertiary center (Pediatric Gastronterology Unit; 4th Pediatric Department, Papageorgiou Hospital; Aristotle University of Thessaloniki; Greece) for symptoms (duration >6 months) indicative of delayed GET between March 2007 and March 2013 were included in the study.

Twenty healthy, age-matched children without any GI symptoms or evidence of other organic disease were also recruited as controls among patients examined at the pediatric outpatient clinic for routine assessment. Inclusion and exclusion criteria are shown in (Table 1).

Table 1 Inclusion and exclusion study criteria

thumblarge

This study had institutional approval and was conducted according to Helsinki Declaration. Written informed consent was obtained from all study participants.

Assessment for potential organic disorders

All children of the present cohort were investigated for the presence of organic diseases with detailed clinical history, careful physical examination and a number of laboratory tests. The latter included complete blood count, baseline biochemistry with liver, pancreatic and renal function tests, C-reactive protein, erythrocyte sedimentation rate, urinalysis with culture, stool microscopy, and screening for celiac disease (total IgA and IgA anti-tissue transglutaminase antibodies) and H. pylori infection (serum anti-H. pylori IgG and IgM antibodies). Mechanical upper GI obstruction or anatomical abnormality was excluded in all patients with a combination of upper GI contrast series and/or esophagogastroduodenoscopy (EGD).

Gastric emptying scintigraphy

After an overnight fast children underwent a 2-h gastric emptying scintigraphy with a standardized meal of solids. The meal consisted of 2 AA scrambled eggs labeled with technetium 99m (99mTc) sulfur colloid (1 mCi), two thin slices of white bread, 1 teaspoon of butter (5 g) and 150mL of water to ease the ingestion process as the patients had to consume the aforementioned meal within 10 min. The amount of the test meal was calculated according to patient body surface area (test meal in g/1.73 m2).

Immediately after meal ingestion all children were placed in the upright position in front of a γ-camera with parallel-hole collimator (Vertex-Plus Epic, ADAC/Philips). Anterior and posterior abdominal images were acquired at 15 min intervals for 1 min for a total duration of 2 h. Areas of interest were subsequently set in the stomach area and the rate at which the radioactive material left the stomach was calculated based on the geometric mean.

Gastric half-emptying time (T1/2) was defined as the time by which 50% of the radiolabeled meal of solids had left the stomach. GET was considered delayed if T1/2 was >90 min.

In the intervals of image acquisition children were allowed to walk outside the γ-camera room; however, and until the test was over, they were neither allowed to eat or drink nor to engage in intense play.

Blood sample collection and analysis

Venous blood samples (4 mL) were collected between 08:00-09:00 am immediately prior to the ingestion of the meal for the scintigraphic gastric emptying study and 2 h later, upon completion of the test. The blood samples were collected into biochemistry tubes (not containing EDTA, aprotinin or hydrochloric acid), and were immediately centrifuged at 4° C for 5 min at 3000 rpm. Sera were subsequently extracted and stored at -24° C.

Serum total GHR and OB were measured using the human GHR and OB RIA commercially available kits (Phoenix Pharmaceuticals, Inc., Burlingame, California, USA). Due to ethical reasons gastric emptying scintigraphy was not performed and only morning fasting blood samples were collected for the measurement of preprandial levels of total GHR and OB in the control group.

Statistical analysis

Patient characteristics, serum levels of GHR and OB, GHR/OB ratio and GET T1/2are expressed as mean ± standard deviation and as median and range depending on the normality of the distributions of continuous variables as assessed with Kolmogorov-Smirnov test.

Comparisons of preprandial GHR and OB as well as GHR/OB ratio between patients and controls were performed with Student’s t-test, whereas paired t-test was used for comparisons between pre- and postprandial levels. Finally, t-test was also used to compare both pre- and postprandial levels between patients with normal and delayed GET. Categorical variables were compared using chi-square test. Furthermore the adjusted effect of different factors [gender, age, body mass index (BMI z-score)] on GET, levels of GHR and OB, GHR/OB (pre- and postprandial) was explored using multiple regression analysis. Statistical analyses were performed with SPSS version 17.0 software (SPSS Inc, Chicago, IL). P values <0.05 were considered statistically significant.

Results

Demographics and clinical characteristics

Twenty prepubertal children (7 male, 35%) with symptoms suggestive of delayed GET (early satiety, postprandial fullness, nausea, vomiting) that remained of unexplained etiology (duration of symptoms >6 months) were identified and included in the study. Of note, the initial diagnostic work-up which included a complete blood count, baseline biochemistry with liver, pancreatic and renal function tests, C-reactive protein, erythrocyte sedimentation rate, urinalysis with culture, stool microscopy, celiac disease (total IgA and IgA antitissue transglutaminase antibodies) and H. pylori (serum IgM and IgG antibodies) screening was within normal range. Furthermore, no mechanical upper GI obstruction or anatomical abnormality was revealed in any patient by means of a combination of upper GI contrast series and/or EGD. Of note, the histopathology of the biopsies taken during all EGD procedures was also without any abnormalities. Demographic data and baseline patient characteristics are presented in (Table 2). Twenty healthy, age-matched controls were also included.

Table 2 Study participants’ clinical characteristics and laboratory findings

thumblarge

GET

Nine of 20 patients had delayed GET (T1/2 >90 min). The median time for gastric emptying rate was 80.5 (range: 55-210) min. GET was not significantly affected by age, gender and BMI (adjusted effect as assessed with regression analysis).

Serum total GHR and OB levels

The preprandial levels of GHR, OB and the GHR/OB ratio were significantly higher in patients compared to controls (P<0.05) (Fig. 1). Postprandially (patient group) there was a decrease in GHR and an increase in OB levels which were not statistically significant; however the postprandial GHR/OB ratio was found to be significantly lower (Fig. 2). Moreover, the postprandial levels of GHR and the GHR/OB ratio (but not OB) were significantly lower in the patients who had delayed GET (P<0.05) (Fig. 3). Pre- and postprandial levels of GHR, OB were not significantly affected by patient/control characteristics (adjusted effect, regression analysis).

thumblarge

Figure 1 Preprandial levels of GHR, OB and GHR/OB ratio in patient and control groups

GHR, ghrelin; OB, obestatin; GHR, OB and GHR/OB values represent mean values

thumblarge

Figure 2 Pre- and postprandial levels of GHR, OB and GHR/OB ratio in patient group

GHR, ghrelin; OB, obestatin; GHR, OB and GHR/OB values represent mean values

thumblarge

Figure 3 Pre- and postprandial levels of GHR, OB and GHR/OB ratio in patients with normal and delayed gastric emptying time (GET)

GHR, ghrelin; OB, obestatin; GHR, OB and GHR/OB values represent mean values

Discussion

In the present study we assessed GET and total GHR, OB serum levels in children with persistent (>6 months) and unexplained symptoms of delayed gastric emptying. We found that: GET was prolonged in 9 out 20 patients; preprandial GHR and OB levels were significantly higher in patients than controls; patients with delayed GET had significantly lower postprandial GHR and GHR/OB ratio compared to those with normal GET.

Approximately 50% (9/20) of the patients had delayed GET of solids as assessed with the gold standard method of scintigraphic imaging of a radiolabeled meal [8,9]. This finding is in line with results published by other researchers and highlights the fact that delayed GE is possibly implicated in the pathogenesis of dyspeptic symptoms [10]. Interestingly, in the other 50% of the patients GET was normal indicating that another cause should be sought for their symptomatology.

The preprandial levels of GHR and OB were higher in our patients as compared to controls. This is an interesting finding which is in contrast with the lower preprandial GHR, OB levels demonstrated by other researchers in adults with functional dyspepsia [11]. Our results however are similar with studies in children with poor appetite and adults with anorexia nervosa (AN) which revealed increased preprandial levels of GHR and OB particularly in AN patients compared to healthy subjects [12-14].

Of note, Ang et al have demonstrated that GHR increases the gastric tone in the fasting state and inhibits gastric accommodation when administered during a meal [15]. The latter could possibly explain the symptoms of early satiety and postprandial fullness in the patients of the present study who had significantly higher preprandial GHR levels.

Finally, we have shown that the postprandial levels of GHR and the GHR/OB ratio are significantly lower amongst patients with delayed GET. Limited data exist on the correlation between GHR and GET in patients with dyspeptic symptoms. Lee et al did not find a significant correlation between pre-/postprandial GHR and GET in adults with dysmotility-like functional dyspepsia, although 5 out 7 patients with abnormally low preprandial GHR had delayed GET [11]. Noteworthily, postprandial OB was found to increase in our patients however this was not statistically significant. The resulting imbalance in the GHR/OB ratio may be implicated in the pathogenesis of dyspeptic symptoms, although further research is required to validate this hypothesis [12,13].

The interplay between gut peptides such as GHR, OB and GI motility is still the subject of research, however due to the scarce data our results are not easily interpreted [11,15,16].

We have measured total GHR, which is considered as an acceptable surrogate for acylated GHR, and not its isoforms (acyl- and des-acyl-GHR) which have opposite biologic properties (acyl-GHR: orexigenic, promotes GI motility, des-acyl-GHR: opposite effects) [3,11,17-19]. A potential imbalance between the two could also partially explain our results.

Polymorphisms in the preproghrelin gene, differences in the transcriptional, translational and post-translational processes could also lead to disturbances in the production of GHR and OB [13,14,20,21]. Moreover the role of sequence variants in the coding region of GHR receptor (growth hormone secretagogue receptor - GHSR1a) and genetic variations of the enzyme responsible for its acylation and thus biologic activity (GHR O-acyltransferase, GOAT) have also been explored in the regulation of body weight in children and in adults with AN, without, however, definitive conclusions [22,23].

Limitations of the present study include the small number of patients and the fact that total serum GHR was measured without discrimination between acyl-GHR which promotes the appetite and GI motility and des-acyl-GHR that has biological properties similar to OB [1]. Moreover, postprandial serum levels of GHR, OB along with scintigraphic evaluation of GET have not been assessed in controls as this was not ethically acceptable. Furthermore amongst the various parameters of the gastric sensorimotor function that could cause symptoms similar to the ones described, GET was the only one assessed, as other diagnostic modalities, e.g. electrogastrogram and barostat, were not available in our institution.

Strengths of the study include the homogeneous and carefully selected population and the fact that it offers a novel insight regarding the role of GHR and OB in children with GI symptoms.

In conclusion, our data suggest that delayed gastric emptying is common in children with unexplained dyspeptic symptoms. In these patients, GHR and OB are deranged suggesting that they may play a role, not as yet fully clarified, in the regulation of gastric motility and the pathogenesis of such symptoms.

Further studies are warranted to fully understand their role, particularly in view of the therapeutic potential of ghrelin in the treatment of gut motility disorders.

Summary Box

What is already known:


  • Ghrelin and obestatin are peptides of the gut-brain axis affecting appetite and gastrointestinal motility

  • Delayed gastric emptying has been implicated in the pathogenesis of dyspeptic symptoms (e.g. early satiety, bloating)

  • The complex mechanisms regulating gastric motility in children are still not well understood

What the new findings are:


  • Delayed gastric emptying was not uncommon in children with unexplained dyspeptic symptoms

  • Serum levels of ghrelin and obestatin were deranged in children with symptoms suggestive of delayed gastric emptying not attributable to any identifiable cause

  • Ghrelin to obestatin ratio seems to affect gastric emptying time in children with the aforementioned symptomatology

References

1. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A, Ghrelin gene products and the regulation of food intake and gut motilityPharmacol Rev 2009; 61: 430-481.

2. Delporte C, Structure and physiological actions of ghrelinScientifica (Cairo) 2013; 2013: 518909.

3. Perboni S, Inui A, Appetite and gastrointestinal motility: role of ghrelin-family peptidesClin Nutr 2010; 29: 227-234.

4. Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T, Dyspepsia in children and adolescents: a prospective studyJ Pediatr Gastroenterol Nutr 2000; 30: 413-418.

5. Riezzo G, Chiloiro M, Guerra V, Borrelli O, Salvia G, Cucchiara S, Comparison of gastric electrical activity and gastric emptying in healthy and dyspeptic childrenDig Dis Sci 2000; 45: 517-524.

6. Rodriguez L, Irani K, Jiang H, Goldstein AM, Clinical presentation, response to therapy, and outcome of gastroparesis in childrenJ Pediatr Gastroenterol Nutr 2012; 55: 185-190.

7. Waseem S, Islam S, Kahn G, Moshiree B, Talley NJ, Spectrum of gastroparesis in childrenJ Pediatr Gastroenterol Nutr 2012; 55: 166-172.

8. Maurer AH, Advancing gastric emptying studies: standardization and new parameters to assess gastric motility and functionSemin Nucl Med 2012; 42: 101-112.

9. Reid B, DiLorenzo C, Travis L, Flores AF, Grill BB, Hyman PE, Diabetic gastroparesis due to postprandial antral hypomotility in childhoodPediatrics 1992; 90: 43-46.

10. Hoffman I, Tack J, Assessment of gastric motor function in childhood functional dyspepsia and obesityNeurogastroenterol Motil 2012; 24: 108-112.e181.

11. Lee KJ, Cha DY, Cheon SJ, Yeo M, Cho SW, Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsiaDigestion 2009; 80: 58-63.

12. Shen C, Yu T, Tang ZH, Wu KM, Changes in ghrelin and obestatin levels before and after a meal in children with simple obesity and anorexiaHorm Res Paediatr 2013; 79: 341-346.

13. Monteleone P, Serritella C, Martiadis V, Scognamiglio P, Maj M, Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosaJ Clin Endocrinol Metab 2008; 93: 4418-4421.

14. Sedlackova D, Kopeckova J, Papezova H, Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosaNutr Metab (Lond) 2012; 9: 52.

15. Ang D, Nicolai H, Vos R, Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in manNeurogastroenterol Motil 2009; 21: 528-533.e528-529

16. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T, Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesisAliment Pharmacol Ther 2005; 22: 847-853.

17. Ariyasu H, Takaya K, Hosoda H, Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelinEndocrinology 2002; 143: 3341-3350.

18. Murakami N, Hayashida T, Kuroiwa T, Role for central ghrelin in food intake and secretion profile of stomach ghrelin in ratsJ Endocrinol 2002; 174: 283-288.

19. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML, Circulating ghrelin levels are decreased in human obesityDiabetes 2001; 50: 707-709.

20. Dardennes RM, Zizzari P, Tolle V, Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onsetPsychoneuroendocrinology 2007; 32: 106-113.

21. Futagami S, Shimpuku M, Kawagoe T, The preproghrelin 3056 TT genotype is associated with the feeling of hunger and low acylated ghrelin levels in Japanese patients with Helicobacter pylori-negative functional dyspepsiaIntern Med 2013; 52: 1155-1163.

22. Muller TD, Tschop MH, Jarick I, Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosaJ Psychiatr Res 2011; 45: 706-711.

23. Wang HJ, Geller F, Dempfle A, Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal statureJ Clin Endocrinol Metab 2004; 89: 157-162.

Notes

Conflict of Interest: None